Drug Chatter -- Tracking biopharma stock chatter

Profile for Lipocine Inc. (LPCN)

« Back to company index

LPCN Chatter Timeline

Stock Ticker for LPCN

Most Active Tweeters for LPCN

UserTweets
@pharmd2828shawn 6
@Stock_Hunter89 4
@ZolmaxNews 4
@MaisaCorp 3
@dispatchtribune 3

Recent Tweets for LPCN

vtcarguy81 @vtcarguy81
RT @vtcarguy81: $LPCN Is Lipocine's Tlando PDUFA delay a positive or negative sign regarding approval?
November 19th 2017, 3:11pm
vtcarguy81 @vtcarguy81
$LPCN Is Lipocine's Tlando PDUFA delay a positive or negative sign regarding approval?
November 17th 2017, 8:11pm
FDAadcomm @FDAadcomm
RT @BioRunUp: $LPCN PDUFA extended to May 8, 2018 to allow time to review additional data analyses recently submitted as an amendment to th…
November 17th 2017, 5:11pm
MaisaCorp @MaisaCorp
$LPCN The previously scheduled Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) meeting on Jan. 1… https://t.co/n8NnDfZh6u
November 17th 2017, 4:11pm
MaisaCorp @MaisaCorp
$LPCN FDA has assigned a new prescription drug user fee act (PDUFA) goal date of May 8.
November 17th 2017, 4:11pm
MaisaCorp @MaisaCorp
$LPCN has extended the review period for the new drug application for TLANDO, the company's oral testosterone prod… https://t.co/hN9faqD2oH
November 17th 2017, 4:11pm
CRWECrownEquity @CRWECrownEquity
FDA Extends review period for $LPCN 's New Drug Application for TLANDO, a novel oral prodrug of testosterone https://t.co/mtrft1qROL
November 17th 2017, 3:11pm
LifeSciAdvisors @LifeSciAdvisors
Lipocine $LPCN: U.S. FDA Extends Review for TLANDO™; Advisory Committee Meeting Date of January 10, 2018 Remains U… https://t.co/UcC7za8Mgc
November 17th 2017, 11:11am
StockNewsNow @StockNewsNow
$LPCN U.S. FDA Extends Review for TLANDO™; Advisory Committee Meeting Date of January 10, 2018 Remains Unchanged https://t.co/Ep5kR6Oibz
November 17th 2017, 10:11am
Briefingcom @Briefingcom
$LPCN: FDA Extends Review for Lipocine's TLANDO: Confirms advisory meeting date is unchanged https://t.co/saYzbWvXSZ
November 17th 2017, 10:11am
QuantchaIdeas @QuantchaIdeas
Big Loser Alert: Trading today’s -7.8% move in LIPOCINE INC. COMMON STOCK $LPCN https://t.co/qJXB2vQKGc https://t.co/OS4s30I1CX
November 17th 2017, 10:11am
pharmd2828shawn @pharmd2828shawn
$LPCN when there is be new information submitted it's always FDA rule they will extend pdufa by 3 months! Nothing to be worried imho
November 17th 2017, 9:11am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
FDA action date for Lipocine's Tlando NDA extended to May 8, 2018; shares down 6% premarket https://t.co/64AHsEWMiI #premarket $LPCN
November 17th 2017, 8:11am
MarketCurrents @MarketCurrents
FDA action date for Lipocine's Tlando NDA extended to May 8, 2018; shares down 6% premarket https://t.co/EqOXqYyc8t #premarket $LPCN
November 17th 2017, 8:11am
mussocpa @mussocpa
$LPCN whats the exact adcom date in December 2017?
November 17th 2017, 8:11am
StockTexts @StockTexts
$LPCN Lipocine Inc. SEC Filing: Form S-3/A https://t.co/XcebZ1Fj8u
November 17th 2017, 8:11am
confcalltran @confcalltran
Registration statement under Securities Act of 1933 https://t.co/4oE5p7WwKI $LPCN
November 17th 2017, 8:11am
confcalltran @confcalltran
Lipocine: U.S. Fda Extends Review For Tlando™, Advisory Committee Meeting Date Of January 10, 2 https://t.co/yQpdHOrQHj $LPCN
November 17th 2017, 8:11am
stockboardinc @stockboardinc
$LPCN U.S. FDA Extends Review for TLANDO™; Advisory Committee Meeting Date of January 10, 2018 Remains U... - https://t.co/SXFkFENVQr
November 17th 2017, 8:11am
BioStocks @BioStocks
$LPCN FDA assigns new PDUFA 05/08/18
November 17th 2017, 8:11am
GNWLive @GNWLive
U.S. FDA Extends Review for TLANDO™; Advisory Committee Meeting Date of January 10, 2018 Remains Unchanged $LPCN https://t.co/z8LFb8PfZU
November 17th 2017, 8:11am
BioRunUp @BioRunUp
$LPCN PDUFA extended to May 8, 2018 to allow time to review additional data analyses recently submitted as an amend… https://t.co/Twy32bpeg5
November 17th 2017, 8:11am
dispatchtribune @dispatchtribune
Lipocine $LPCN and Its Peers Financial Survey https://t.co/vpoVTmy5BV
November 16th 2017, 6:11pm
calgarycraig20 @calgarycraig20
$LPCN sold today for apprx. 5%
November 16th 2017, 6:11pm
osok762 @osok762
Good news for all of the companies in TRT $LPCN https://t.co/NSRXljSe7H
November 16th 2017, 4:11pm
pharmd2828shawn @pharmd2828shawn
$LPCN I told u going higher
November 16th 2017, 11:11am
bkfViking123 @bkfViking123
$lpcn tiny burn rate .... plenty of cash .... wedge ... looking to trade over the 200 day into jan. https://t.co/WGPkzlTmX6
November 16th 2017, 11:11am
pharmd2828shawn @pharmd2828shawn
$LPCN so cheap ...imho going much higher
November 16th 2017, 10:11am
Stock_Hunter89 @Stock_Hunter89
$LPCN swing looking ready to go +++
November 16th 2017, 10:11am
pharmd2828shawn @pharmd2828shawn
$LPCN based on public data this stock should go much higher in the next 2 months..imho MC is super low
November 16th 2017, 8:11am
storminvestor @storminvestor
-$0.27 Earnings Per Share Expected for Lipocine Inc. $LPCN This Quarter https://t.co/m3MxwM8y7R
November 15th 2017, 6:11pm
SPNewsAnalysis @SPNewsAnalysis
-$0.27 Earnings Per Share Expected for Lipocine Inc. $LPCN This Quarter https://t.co/ivKQ0S9a7S
November 15th 2017, 6:11pm
Stock_Hunter89 @Stock_Hunter89
$LPCN nice base hold today given current conditions hopefully bottom is in at 3.50
November 15th 2017, 11:11am
realmaciej @realmaciej
RT @BioRunUp: $LPCN 1/10/18 AdCom announced in today's FedReg (oral testosterone undecanoate capsules) https://t.co/PEIddQidkH
November 15th 2017, 8:11am
BioRunUp @BioRunUp
$LPCN 1/10/18 AdCom announced in today's FedReg (oral testosterone undecanoate capsules) https://t.co/PEIddQidkH
November 15th 2017, 8:11am
tsilver_apex @tsilver_apex
$LPCN adcomm scheduled for Jan 10, 2018 - oral testosterone undecanoate capsules
November 15th 2017, 8:11am
dispatchtribune @dispatchtribune
Lipocine $LPCN Earning Somewhat Positive Press Coverage, Report Shows https://t.co/ANt4xkd9SW
November 14th 2017, 4:11pm
TheMarketsDaily @TheMarketsDaily
Lipocine $LPCN Earning Somewhat Positive Press Coverage, Report Shows https://t.co/u15UQNgIlM
November 14th 2017, 4:11pm
MarcHarper8472 @MarcHarper8472
I really recommend everyone check this out for finding good stocks to trade https://t.co/BdLvSUT1lt $LOGM $LPCN… https://t.co/wAnI4Z6bXy
November 14th 2017, 1:11am
surveyist @surveyist
RT @JSTBiotech: $LPCN should be a relatively easy win on data in June, as the drug already succeeded in its previous ph3. No ATM usage/insi…
November 13th 2017, 11:11pm
WillMelton2 @WillMelton2
RT @pharmd2828shawn: $LPCN supper undervalued based on available data ! It could run hard .. imho
November 13th 2017, 4:11pm
pharmd2828shawn @pharmd2828shawn
$LPCN supper undervalued based on available data ! It could run hard .. imho
November 13th 2017, 7:11am
AmericanBanking @AmericanBanking
Analysts Give Average Rating of Buy to Lipocine $LPCN https://t.co/Sl4XMCMFob
November 12th 2017, 11:11am
AmericanBanking @AmericanBanking
Lipocine Gets Average Rating of Buy from Analysts $LPCN https://t.co/Sl4XMCMFob
November 12th 2017, 11:11am
CFinancialNews @CFinancialNews
Zacks: Analysts Expect Lipocine Inc. $LPCN to Post -$0.27 Earnings Per Share https://t.co/vhX6xotb3t
November 12th 2017, 11:11am
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Lipocine Inc. $LPCN to Post -$0.27 Earnings Per Share https://t.co/HEpn0HNi32
November 12th 2017, 11:11am
ZolmaxNews @ZolmaxNews
Ameriprise Financial Inc. Acquires 24,000 Shares of Lipocine Inc. $LPCN https://t.co/y30uyMd9BN
November 12th 2017, 5:11am
ZolmaxNews @ZolmaxNews
$LPCN - Ameriprise Financial Inc. Acquires 24,000 Shares of Lipocine Inc. #LPCN https://t.co/n8U1kPSht7
November 12th 2017, 5:11am
rogerthat191 @rogerthat191
$LPCN first stop 200MA and then $4.40 test coming IMO. Upcoming catalysts in Jan and Feb. https://t.co/wK59LFGY6Z
November 11th 2017, 5:11pm
ResearchPool @ResearchPool
$LPCN #Lipocine Inc LPCN: Resubmission Complete; Preparing for AdCom https://t.co/XbKbhMtWeG #stocks https://t.co/3Ev9d4DesG
November 11th 2017, 4:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.